Poly6 treatment also enhanced expression of DC maturation markers CD40, CD80, CD86, and MHC class II molecules in tumor and draining lymph node tissues in MC38-bearing mice (Figure 4C,D). This evidence concerns the gene CD86 and neoplasm.